Your shopping cart is currently empty

Dextran sulfate sodium salt (MW 4500-5500) is a polymer of dehydrated glucose and an inhibitor of complement and coagulation pathways. Dextran sulfate sodium salt (MW 4500-5500) can be used as an anticoagulant, antiviral agent and antilipidemic agent. Dextran sulfate sodium salt (MW 4500-5500) can prevent the HIV-1 virus from adsorbing onto host cells. Dextran sulfate sodium salt (MW 4500-5500) can inhibit NK cell-mediated cytotoxicity. Dextran sulfate sodium salt (MW 4500-5500) can inhibit the immediate blood-mediated inflammatory response (IBMIR).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 g | $40 | - | In Stock | |
| 25 g | $81 | - | In Stock | |
| 50 g | $128 | - | In Stock |
| Description | Dextran sulfate sodium salt (MW 4500-5500) is a polymer of dehydrated glucose and an inhibitor of complement and coagulation pathways. Dextran sulfate sodium salt (MW 4500-5500) can be used as an anticoagulant, antiviral agent and antilipidemic agent. Dextran sulfate sodium salt (MW 4500-5500) can prevent the HIV-1 virus from adsorbing onto host cells. Dextran sulfate sodium salt (MW 4500-5500) can inhibit NK cell-mediated cytotoxicity. Dextran sulfate sodium salt (MW 4500-5500) can inhibit the immediate blood-mediated inflammatory response (IBMIR). |
| Targets&IC50 | HIV-1:9.1 µg/mL |
| In vitro | METHODS: MT-4 cells were treated with Dextran sulfate sodium salt (MW 4500-5500) (25 μg/mL) for 24 hours. The inhibitory effect on HIV-1 replication was observed, and the effects of the drug on cytotoxicity and reverse transcriptase activity were evaluated. RESULTS: Dextran sulfate sodium salt (MW 4500-5500) has a significant selective inhibitory effect on HIV-1, with an IC50 value of 2.3-8.8 µg/ml, and does not show toxicity to host cells at high concentrations. [1] |
| In vivo | METHODS: To investigate the effect of Dextran sulfate sodium salt (MW 4500-5500) on endothelial injury after ischemia and reperfusion in a rat model of inferior renal aortic clamp, Dextran sulfate sodium salt (MW 4500-5500)(5 mg/mL, 200 μL) was immediately locally infused into the ischemic aortic segment of rats before reperfusion. RESULTS: Dextran sulfate sodium salt (MW 4500-5500) inhibits complement activation and reduces endothelial injury after ischemia and reperfusion in the rat model of inferior renal aortic clamp. [2] |
| Synonyms | DSS, Dextran sulfate sodium salt (MW 5000) |
| Molecular Weight | 9000-20000 |
| Formula | (C6H7Na3O14S3)n |
| Cas No. | 9011-18-1 |
| Relative Density. | no data available |
| Storage | In solvent: -80°C for 1 year |
| Solubility Information | H2O: 100 mg/mL, Sonication is recommended. DMSO: Insoluble |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.